Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Ran Stark

Plastic Surgery Bryn Mawr, PA Medical Doctor

NPI 1376779389 CMS profile 1396877

135 S Bryn Mawr Ave Ste 220, Bryn Mawr, PA 19010

Open in the dashboard

General payments

$84,642

303 records reported · program years 2019–2025

Research payments

$600

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Ran Stark of Bryn Mawr, PA is reported in the CMS Open Payments database as having received $84,642 across 303 general payments and $600 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Plastic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

8 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,093 52
2024 General $9,405 46
2024 Research $600 1
2023 General $14,397 40
2022 General $22,532 46
2021 General $329 20
2020 General $24,703 39
2019 General $9,184 60

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Ran Stark
  • Plastic Surgery median
  • Middle half of Plastic Surgery
  • National median

In program year 2025, general payments to Ran Stark were reported at $4,093. Among 3,701 Plastic Surgery profiles paid that year, the median was $379 and the middle half received between $138 and $1,100.

Show as a table
Year Ran Stark Plastic Surgery median Middle half National median
2019 $9,184 $371 $122–$1,483 $163
2020 $24,703 $158 $52–$438 $114
2021 $329 $249 $87–$752 $132
2022 $22,532 $274 $102–$793 $149
2023 $14,397 $299 $113–$891 $160
2024 $9,405 $361 $124–$1,062 $164
2025 $4,093 $379 $138–$1,100 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Allergan Inc. $46,913 136 payments
  2. AbbVie, Inc. $21,991 91 payments
  3. Galderma Laboratories, L.P. $8,778 17 payments
  4. Motiva USA, LLC $5,624 35 payments
  5. Sientra, Inc. $436 8 payments
  6. Tepha Inc $433 6 payments
  7. Solta Medical, a division of Bausch Health US, LLC $237 2 payments
  8. Mentor Worldwide LLC $147 3 payments
  9. Merz North America, Inc. $26 1 payment
  10. Integra LifeSciences Corporation $21 1 payment
  11. Other $37 3 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $32,500 8 payments
  2. Consulting Fee $19,776 5 payments
  3. Travel and Lodging $16,076 25 payments
  4. Food and Beverage $9,309 260 payments
  5. Gift $6,982 5 payments
Products named General payments · program years 2019–2025
  1. BOTOX COSMETIC $25,075 45 payments
  2. BOTOX $9,610 17 payments
  3. NATRELLE $7,406 18 payments
  4. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastic Surgery $7,327 30 payments
  5. Motiva Implant Matrix Devices $2,999 28 payments
  6. Motiva Implant Matrix Plastic Surgery $2,578 6 payments
  7. SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT $436 8 payments
  8. GalaFLEX $433 6 payments
  9. NATRELLE SALINE-FILLED BREAST IMPLANTS Plastics $148 15 payments
  10. MemoryGel Breast Implants $119 1 payment
  11. Other $225 11 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Motiva USA, LLC $600 1 payment

Records

304 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Plastic Surgery in Pennsylvania

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record